LD-2 disclosure · 4th Quarter - Report
IGM BIOSCIENCES, INC.
via IGM BIOSCIENCES, INC.
Client
- Name
- IGM BIOSCIENCES, INC.
- Location
- California · United States of America
Registrant
- Firm
- IGM BIOSCIENCES, INC.
- Description
- ​Development of engineered IgM antibodies
- Location
- Mountain View, California, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
COVID Supplemental Appropriation S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to the development of an antibody therapy for COVID-19 Issues related to antimicrobial resistance (AMR) and drug development Issues related to supply chain and biopharmaceutical manufacturing FY2024 Defense Appropriations Issues related to the reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) National Biodefense Strategy and Implementation Plan H.R.3746 Fiscal Responsibility Act of 2023 H.R.4421 Preparing for All Hazards and Pathogens Reauthorization Act
Lobbyistsmr ANDREW WESLEY WOMACK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS)